Search

everythinglearnresearchcommunity

for

Search:↓

The Wnt/β-catenin pathway is important for body functions and diseases, and targeting it may treat conditions like cancer, but with safety challenges.

Different STUB1 gene mutations cause varied symptoms in autosomal recessive ataxias.

New therapies are being developed that target integrin pathways to treat various diseases.

Botulinum A toxin injections reduced pain and promoted hair regrowth in a woman with a rare form of alopecia areata.

Tamarix aphylla may be effective for various medical conditions, but more research is needed to confirm its safety and effectiveness.

Grateloupia elliptica extract may help prevent hair loss and promote hair growth.

The workshop discussed the role of a protein called calreticulin in health and disease, its potential as a treatment target, and its possible use as a disease marker.

Hair follicle studies suggest that maintaining telomere length could help treat hair loss and graying, but it's uncertain if mouse results apply to humans.

The study suggests that mast cells might be involved in the hair loss condition telogen effluvium and could be a target for treatment.

Autophagy helps keep skin healthy and may improve treatments for skin diseases.

Some diets and supplements might help with skin disorders, but their effectiveness varies and more research is needed.

FGF21 can help reduce skin inflammation caused by C. acnes.

Enzymes called PADIs play a key role in hair growth and loss.

Heat Shock Proteins are important in the development of Polycystic Ovarian Syndrome and could be targets for new treatments.

People with alopecia areata may also have allergic rhinitis and should be checked for respiratory allergies.

Light therapy is effective and safe for treating skin color disorders like vitiligo and dark spots.

Forsythiasides have multiple health benefits but may cause pseudoallergic reactions, and more research is needed.

A man with X-ALD improved after treatment, highlighting the need to consider X-ALD in similar patients and test their relatives.

Rare ULBP3 gene changes may raise the risk of Alopecia areata, a certain FAS gene deletion could cause a dysfunctional protein in an immune disorder, and having one copy of a specific genetic deletion is okay, but two copies cause sickle cell disease.

The convention discussed various skin conditions and treatments, and highlighted the importance of vaccinations for patients on immune-altering medications.

Enzymes are classified into six types and are essential for many biological processes, with only a few targeted by drugs.

Early recognition and treatment of SLE can improve outcomes in patients with complex symptoms.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.

Vitamin B5 and coenzyme A may help regulate the immune system and could improve treatments for chronic diseases and cancer.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

Mitochondrial dysfunction is linked to various skin conditions and could be a target for treatments.

Light therapy on the brain shows promise for treating brain diseases and improving brain function.

Non-scarring hair loss in lupus patients often responds well to treatment and doesn't lead to scarring.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

Hair loss in Androgenetic Alopecia is caused by genetics, aging, and lifestyle, leading to hair follicle shrinkage and related health risks.